BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22203606)

  • 1. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
    Lavender H; Brady K; Burden F; Delpuech-Adams O; Denise H; Palmer A; Perkins H; Savic B; Scott S; Smith-Burchnell C; Troke P; Wright JF; Suhy D; Corbau R
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1364-75. PubMed ID: 22203606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
    Suhy DA; Kao SC; Mao T; Whiteley L; Denise H; Souberbielle B; Burdick AD; Hayes K; Wright JF; Lavender H; Roelvink P; Kolykhalov A; Brady K; Moschos SA; Hauck B; Zelenaia O; Zhou S; Scribner C; High KA; Renison SH; Corbau R
    Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line.
    Elbadawy HM; Mohammed Abdul MI; Aljuhani N; Vitiello A; Ciccarese F; Shaker MA; Eltahir HM; Palù G; Di Antonio V; Ghassabian H; Del Vecchio C; Salata C; Franchin E; Ponterio E; Bahashwan S; Thabet K; Abouzied MM; Shehata AM; Parolin C; Calistri A; Alvisi G
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X; Haurigot V; Zhou S; Luo G; Couto LB
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HCV replication by small interfering RNA.
    Ray RB; Kanda T
    Methods Mol Biol; 2009; 510():251-62. PubMed ID: 19009267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons.
    Hamazaki H; Ujino S; Miyano-Kurosaki N; Shimotohno K; Takaku H
    Biochem Biophys Res Commun; 2006 May; 343(3):988-94. PubMed ID: 16566896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy.
    Suzuki H; Matsumoto N; Suzuki T; Chang MO; Takaku H
    Virol J; 2009 Oct; 6():156. PubMed ID: 19796392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
    Sakamoto N; Tanabe Y; Yokota T; Satoh K; Sekine-Osajima Y; Nakagawa M; Itsui Y; Tasaka M; Sakurai Y; Cheng-Hsin C; Yano M; Ohkoshi S; Aoyagi Y; Maekawa S; Enomoto N; Kohara M; Watanabe M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
    Mockenhaupt S; Grosse S; Rupp D; Bartenschlager R; Grimm D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4007-16. PubMed ID: 26170322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication.
    Pei Z; Shi G; Kondo S; Ito M; Maekawa A; Suzuki M; Saito I; Suzuki T; Kanegae Y
    Sci Rep; 2013 Dec; 3():3575. PubMed ID: 24356586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
    Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
    Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme gene therapy for hepatitis C virus infection.
    Welch PJ; Yei S; Barber JR
    Clin Diagn Virol; 1998 Jul; 10(2-3):163-71. PubMed ID: 9741642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs.
    Yokota T; Sakamoto N; Enomoto N; Tanabe Y; Miyagishi M; Maekawa S; Yi L; Kurosaki M; Taira K; Watanabe M; Mizusawa H
    EMBO Rep; 2003 Jun; 4(6):602-8. PubMed ID: 12740604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
    ElHefnawi M; Kim T; Kamar MA; Min S; Hassan NM; El-Ahwany E; Kim H; Zada S; Amer M; Windisch MP
    PLoS One; 2016; 11(7):e0159211. PubMed ID: 27441640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RNA Interference/Adeno-Associated Virus Vector-Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus.
    Zhang C; Freistaedter A; Schmelas C; Gunkel M; Dao Thi VL; Grimm D
    Hepatol Commun; 2022 Apr; 6(4):878-888. PubMed ID: 34719133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication.
    Mandal A; Chaubey B
    Intervirology; 2018; 61(2):79-91. PubMed ID: 30253401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.